| IPO Company Profile |
| SEC Filings | Peer IPO Companies |
| SCNV Acquisition Corp. |
| 7 Ben Zvi Road, Beer-Sheva, Israel 84893 |
| The company was organized to select, develop and commercially exploit proprietary technologies, in various stages of development, invented primarily by scientists who have recently immigrated to Israel from Russia and the former Soviet Union. |
| Manager | Tier | Phone |
| Patterson Travis, Inc. | Lead Manager | (212) 837-7340 |
| NASSCM: | SOLM | Manufacturing: | SIC 3629 | |
| Type of Shares: | Common Shares | Filing Date: | 1/9/98 | |
| U.S. Shares Filed: | 1,460,000 | Filing Price: | $4.00 | |
| Non-U.S. Shares Filed: | 0 | Offering Amount: | $5,840,000 | |
| Primary Shares: | 1,460,000 | Expenses: | $179,580 | |
| Secondary Shares: | 0 | Post-IPO Shares: | 2,920,000 | |
| Employees: | 8 |
| Issuer's Law Firm: | Tenzer, Greenblatt, Fallon & Kaplan |
| Bank's Law Firm: | Bernstein & Wasserman |
| Registrar/Transfer Agent: | American Stock Transfer & Trust Co |
| Auditor: | Arthur Andersen |
Dollar amounts in U.S. millions except for per share data | |||||
| 3 Month Ending Financials | |||||
| Full Year Audited Income | Latest Unaudited Income | Prior Audited Income | Balance Sheet | ||
| 6/30/97 | 9/30/97 | 9/30/96 | 9/30/97 | ||
| Revenue: | $0.06 | $0.01 | $27.25 | Assets: | $0.05 |
| Net Income: | -$0.66 | -$0.15 | -$0.14 | Curr Assets: | |
| EPS: | -$0.45 | -$0.10 | -$0.10 | Liabilities: | $0.04 |
| Prior EPS: | -$0.44 | Curr Liab: | $0.03 | ||
| Cash Flow/Oper: | Equity: | $0.01 | |||
| Cash Flow/Fin: | Cash: | ||||
| Cash Flow/Inv: | |||||
| Competition |
| The products that will be based on the Company's technologies will likely be used in highly competitive industries. Numerous domestic and foreign companies are seeking to research, develop and commercialize technologies similar to those of the Company, many of which have greater name recognition and financial, technical, marketing, personnel and research capabilities than the Company. There can be no assurance that the Company's competitors will not succeed in developing technologies and applications that are more cost effective, or have fewer limitations than, or have other advantages as compared to, the Company's technologies. The markets for the technologies and products to be developed or acquired by the Company are characterized by rapid changes and evolving industry standards often resulting in product obsolescence or short product lifecycles. Accordingly, the ability of the Company to compete will depend on its ability to complete development and introduce to the marketplace, directly or through strategic partners, in a timely manner its proposed products and technologies, to continually enhance and improve such products and technology, to adapt its proposed products to be compatible with specific products manufactured by others, and to successfully develop and market new products and technologies. There can be no assurance that the Company will be able to compete successfully, that its competitors or future competitors will not develop technologies or products that render the Company's products and technologies obsolete or less marketable or that the Company will be able to successfully enhance its proposed products or technologies or adapt them satisfactorily. The Company believes that Solmecs is the only commercial company engaged in the development of LMMHD generator systems. However, the Company believes that the competition in the worldwide market for energy conversion systems is intense and the Company may encounter substantial competition from other companies engaged in the development of competing energy conversion systems which companies may have grater name recognition and financial, technical, marketing, personnel and research capabilities than the Company. There can be no assurance that other companies are not dedicated to identifying, obtaining and developing technologies of Russian scientists and engineers currently residing in Israel. Any such competitors may have greater financial, technical, marketing, personnel and other resources than the Company. |
| Business Plan |
| The Company's strategy is to identify and exploit innovative technologies which represent advances over existing products or technologies. The Company plans to implement its strategy through a four-step process: (I) Identify potential business opportunities, (ii) Assess project scientific and commercial viability, (iii) Create a business plan and (iv) Commercialize technologies. |
| Use of Proceeds |
| The proceeds from the proposed offering will be used for market research and marketing activities, research and development, establishment of manufacturing capabilities, acquisition of intellectual property rights, costs relating to the acquisition of Solmecs, repayment of indebtedness and general corporate purposes and working capital. |
| Additional Underwriter Compensation |
| Additional compensation of $179,580. |
| Warrant to purchase 146,000 shares/units at $146.00 per share/unit. |
| Exercise price of $4.92 for 4 year(s), 0 year(s) from . |
| # of Units: | 1,460,000 | |||
| Unit Ticker: | SOLMU | Unit Price: | $4.10 | |
| Warrant Ticker: | SOLMW | Warrant Price: | $0.10 | |
| Warrant Exercise Date: | Warrant Exercise Price: | $5.50 | ||
| Warrant Expiration Date: | ||||
| Warrant Detachable: | Yes | Warrant Detach Date: | ||
| Warrant Callable: | Yes | Warrant Call Date: |
| Unit Composition: 1 Common Share + 1 Class A Warrant |
| Warrant Entitlement: 1 Common Share |
| 5.00% of the proceeds from the exercise of warrants goes to the underwriter. |